By Stephanie Brown HealthDay ReporterMONDAY, Aug. 25, 2025 (HealthDay News) -- The U.S. Food and Drug Administration is ...

A new at home flu-vaccine is hitting the market.AstraZeneca’s Flu-Mist, which has Food and Drug Administration approval, can now be home delivered to people in 34 states under the brand name “flu-mist ...

A bill package proposes requiring vaccines to be covered by private insurance and Medicaid in Pennsylvania. The bills, ...

According to the vaccine's maker, Valneva, the FDA based its decision to suspend the shot on four new serious adverse events ...

There have been 4 new reports of serious adverse events related to Ixchiq based on updated Vaccine Adverse Event Reporting System data.

Dining under palm trees on a patio at Mar-a-Lago in December, President-elect Donald Trump reassured chief executives at ...

Less than three weeks after lifting a pause on the use of Valneva’s chikungunya vaccine Ixchiq, the FDA has done an ...

Hey, good morning. Today, we see CBER suspend the license for a chikungunya vaccine, look at a push to recall a safety and ...

Valneva shares dropped after it said it will no longer be able to sell its chikungunya vaccine in the U.S. after reports linked the vaccine to adverse effects. Shares trading in New York were nearly ...

The FDA Adverse Event Reporting System, which Commissioner Marty Makary called “clunky,” previously published updates on a ...

Those with private health insurance expected to have an easier time getting vaccines than those on Medi-Cal if CDC changes ...

Good morning. For all our talk about potato chips in this newsletter, nobody has ever attempted to give a STAT reporter a wad ...